CURRENT POSSIBILITIES OF ANTI-INFLAMMATORY THERAPY IN PULMONOLOGY
- 作者: Shmelev E.1, Shmelev N.1
-
隶属关系:
- Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences, Moscow
- 期: 卷 23, 编号 2 (2012)
- 页面: 19
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115317
- ID: 115317
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
The paper gives updates on a basically new direction in anti-inflammatory therapy with the phosphodiesterase 4 inhibitor roflumilast in patients with chronic obstructive pulmonary disease. It describes the mechanisms of action of the drug and indications for its use. The results of clinical trials and the possibility of using roflumilast for other lung diseases are described.
全文:
作者简介
E. Shmelev
Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences, Moscow
Email: eishmelev@mail.ru
Department of Pulmonology
N. Shmelev
Central Research Institute of Tuberculosis, Russian Academy of Medical Sciences, MoscowDepartment of Pulmonology
参考
补充文件
